Evidence of oxidative stress in the pathogenesis of fuchs endothelial corneal dystrophy

American Journal of Pathology

Volumn 177, Issue 5, 2010, Pages 2278-2289

  Jurkunas, Ula V ^a,b,c   Bitar, Maya S ^a,c,d   Funaki, Toshinari ^a,c   Azizi, Behrooz ^a,c  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ANTIOXIDANT; BETA ACTIN; BIOLOGICAL MARKER; OXIDIZING AGENT; TRANSCRIPTION FACTOR NRF2;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT RESPONSIVE ELEMENT; APOPTOSIS; ARTICLE; CELL LOSS; CELL STRUCTURE; CONTROLLED STUDY; CORNEA DYSTROPHY; CORNEA ENDOTHELIUM; CORNEA TRANSPLANTATION; DNA DAMAGE; DOWN REGULATION; ENDOTHELIUM CELL; EX VIVO STUDY; FEMALE; FUCHS ENDOTHELIAL CORNEAL DYSTROPHY; GENOME; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; KERATOPATHY; MALE; MITOCHONDRION; MOUSE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PSEUDOPHAKIA; PSEUDOPHAKIC BULLOUS KERATOPATHY;

EID: 78149321314     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.100279     Document Type: Article

References (55)

1. Wilson SE, Bourne WM: Fuchs' dystrophy. Cornea 1988, 7:2-18
2. Darlington JK, Adrean SD, Schwab IR: Trends of penetrating keratoplasty in the United States from 1980 to 2004. Ophthalmology 2006, 113:2171-2175
3. Cross HE, Maumenee AE, Cantolino SJ: Inheritance of Fuchs' endothelial dystrophy. Arch Ophthalmol 1971, 85:268-272
4. Krachmer JH, Purcell JJ, Jr., Young CW, Bucher KD: Corneal endothelial dystrophy: a study of 64 families. Arch Ophthalmol 1978, 96:2036-2039
5. Vithana EN, Morgan PE, Ramprasad V, Tan DT, Yong VH, Venkataraman D, Venkatraman A, Yam GH, Nagasamy S, Law RW, Rajagopal R, Pang CP, Kumaramanickevel G, Casey JR, Aung T: SLC4A11 mutations in Fuchs endothelial corneal dystrophy. Hum Mol Genet 2008, 17:656-666
6. Borderie VM, Baudrimont M, Vallee A, Ereau TL, Gray F, Laroche L: Corneal endothelial cell apoptosis in patients with Fuchs' dystrophy. Invest Ophthalmol Vis Sci 2000, 41:2501-2505
7. Li QJ, Ashraf MF, Shen DF, Green WR, Stark WJ, Chan CC, O'Brien TP: The role of apoptosis in the pathogenesis of Fuchs endothelial dystrophy of the cornea. Arch Ophthalmol 2001, 119:1597-1604
8. Waring GO, 3rd, Bourne WM, Edelhauser HF, Kenyon KR: The corneal endothelium: normal and pathologic structure and function. Ophthalmology 1982, 89:531-590
9. Wang Z, Handa JT, Green WR, Stark WJ, Weinberg RS, Jun AS: Advanced glycation end products and receptors in Fuchs' dystrophy corneas undergoing Descemet's stripping with endothelial keratoplasty. Ophthalmology 2007, 114:1453-1460
10. Buddi R, Lin B, Atilano SR, Zorapapel NC, Kenney MC, Brown DJ: Evidence of oxidative stress in human corneal diseases. J Histochem Cytochem 2002, 50:341-351
11. Jurkunas UV, Rawe I, Bitar MS, Zhu C, Harris DL, Colby K, Joyce NC: Decreased expression of peroxiredoxins in Fuchs' endothelial dystrophy. Invest Ophthalmol Vis Sci 2008, 49:2956-2963
12. Borboli S, Colby K: Mechanisms of disease: fuchs' endothelial dystrophy. Ophthalmol Clin North Am 2002, 15:17-25
13. Zhang C, Bell WR, Sundin OH, De La Cruz Z, Stark WJ, Green WR, Gottsch JD: Immunohistochemistry and electron microscopy of early-onset fuchs corneal dystrophy in three cases with the same L450W COL8A2 mutation. Trans Am Ophthalmol Soc 2006, 104:85-97
14. Ishii T, Itoh K, Takahashi S, Sato H, Yanagawa T, Katoh Y, Bannai S, Yamamoto M: Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem 2000, 275:16023-16029
15. Shih AY, Johnson DA, Wong G, Kraft AD, Jiang L, Erb H, Johnson JA, Murphy TH: Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress. J Neurosci 2003, 23:3394-3406
16. Blank V: Small Maf proteins in mammalian gene control: mere dimerization partners or dynamic transcriptional regulators? J Mol Biol 2008, 376:913-925
17. Joyce NC, Zhu CC: Human corneal endothelial cell proliferation: potential for use in regenerative medicine. Cornea 2004, 23:S8-S19
18. Bednarz J, Teifel M, Friedl P, Engelmann K: Immortalization of human corneal endothelial cells using electroporation protocol optimized for human corneal endothelial and human retinal pigment epithelial cells. Acta Ophthalmol Scand 2000, 78:130-136
19. Rushmore TH, Morton MR, Pickett CB: The antioxidant responsive element: activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J Biol Chem 1991, 266:11632-11639
20. Jurkunas UV, Bitar M, Rawe I: Colocalization of increased transforming growth factor-beta-induced protein (TGFBIp) and Clusterin in Fuchs endothelial corneal dystrophy. Invest Ophthalmol Vis Sci 2009, 50:1129-1136
21. Jurkunas UV, Bitar MS, Rawe I, Harris DL, Colby K, Joyce NC: Increased clusterin expression in Fuchs' endothelial dystrophy. Invest Ophthalmol Vis Sci 2008, 49:2946-2955
22. Zhang J, Ohta T, Maruyama A, Hosoya T, Nishikawa K, Maher JM, Shibahara S, Itoh K, Yamamoto M: BRG1 interacts with Nrf2 to selectively mediate HO-1 induction in response to oxidative stress. Mol Cell Biol 2006, 26:7942-7952
23. Hamilton ML, Van Remmen H, Drake JA, Yang H, Guo ZM, Kewitt K, Walter CA, Richardson A: Does oxidative damage to DNA increase with age? Proc Natl Acad Sci USA 2001, 98:10469-10474
24. Lu T, Pan Y, Kao SY, Li C, Kohane I, Chan J, Yankner BA: Gene regulation and DNA damage in the ageing human brain. Nature 2004, 429:883-891
25. Nakabeppu Y, Tsuchimoto D, Yamaguchi H, Sakumi K: Oxidative damage in nucleic acids and Parkinson's disease. J Neurosci Res 2007, 85:919-934
26. Wang AL, Lukas TJ, Yuan M, Neufeld AH: Increased mitochondrial DNA damage and down-regulation of DNA repair enzymes in aged rodent retinal pigment epithelium and choroid. Mol Vis 2008, 14:644-651
27. Valavanidis A, Vlahoyianni T, Fiotakis K: Comparative study of the formation of oxidative damage marker 8-hydroxy-2′-deoxyguanosine (8-OHdG) adduct from the nucleoside 2′-deoxyguanosine by transition metals and suspensions of particulate matter in relation to metal content and redox reactivity. Free Radic Res 2005, 39:1071-1081
28. Ryter SW, Kim HP, Hoetzel A, Park JW, Nakahira K, Wang X, Choi AM: Mechanisms of cell death in oxidative stress. Antioxid Redox Signal 2007, 9:49-89
29. Cho KS, Lee EH, Choi JS, Joo CK: Reactive oxygen species-induced apoptosis and necrosis in bovine corneal endothelial cells. Invest Ophthalmol Vis Sci 1999, 40:911-919
30. Joyce NC, Zhu CC, Harris DL: Relationship among oxidative stress, DNA damage, and proliferative capacity in human corneal endothelium. Invest Ophthalmol Vis Sci 2009, 50:2116-2122
31. Simonian NA, Coyle JT: Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol 1996, 36:83-106
32. Kraft AD, Johnson DA, Johnson JA: Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J Neurosci 2004, 24:1101-1112
33. Guzik TJ, Sadowski J, Guzik B, Jopek A, Kapelak B, Przybylowski P, Wierzbicki K, Korbut R, Harrison DG, Channon KM: Coronary artery superoxide production and nox isoform expression in human coronary artery disease. Arterioscler Thromb Vasc Biol 2006, 26:333-339
34. Hancock JT, Desikan R, Neill SJ: Role of reactive oxygen species in cell signalling pathways. Biochem Soc Trans 2001, 29:345-350
35. Thorpe GW, Fong CS, Alic N, Higgins VJ, Dawes IW: Cells have distinct mechanisms to maintain protection against different reactive oxygen species: oxidative-stress-response genes. Proc Natl Acad Sci USA 2004, 101:6564-6569
36. Lyakhovich VV, Vavilin VA, Zenkov NK, Menshchikova EB: Active defense under oxidative stress: the antioxidant responsive element. Biochemistry (Mosc) 2006, 71:962-974
37. Hwang YP, Kim HG, Han EH, Jeong HG: Metallothionein-III protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a PI3K and ERK/Nrf2-dependent manner. Toxicol Appl Pharmacol 2008, 231:318-327
38. Li J, Johnson D, Calkins M, Wright L, Svendsen C, Johnson J: Stabilization of Nrf2 by tBHQ confers protection against oxidative stress-induced cell death in human neural stem cells. Toxicol Sci 2005, 83:313-328
39. Lee JM, Calkins MJ, Chan K, Kan YW, Johnson JA: Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. J Biol Chem 2003, 278:12029-12038
40. Li N, Alam J, Venkatesan MI, Eiguren-Fernandez A, Schmitz D, Di Stefano E, Slaughter N, Killeen E, Wang X, Huang A, Wang M, Miguel AH, Cho A, Sioutas C, Nel AE: Nrf2 is a key transcription factor that regulates antioxidant defense in macrophages and epithelial cells: protecting against the proinflammatory and oxidizing effects of diesel exhaust chemicals. J Immunol 2004, 173:3467-3481
41. Lee JM, Li J, Johnson DA, Stein TD, Kraft AD, Calkins MJ, Jakel RJ, Johnson JA: Nrf2, a multi-organ protector? FASEB J 2005, 19:1061-1066
42. Chen W, Sun Z, Wang XJ, Jiang T, Huang Z, Fang D, Zhang DD: Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response. Mol Cell 2009, 34:663-673
43. Ramsey CP, Glass CA, Montgomery MB, Lindl KA, Ritson GP, Chia LA, Hamilton RL, Chu CT, Jordan-Sciutto KL: Expression of Nrf2 in neurodegenerative diseases. J Neuropathol Exp Neurol 2007, 66:75-85
44. Rangasamy T, Cho CY, Thimmulappa RK, Zhen L, Srisuma SS, Kensler TW, Yamamoto M, Petrache I, Tuder RM, Biswal S: Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest 2004, 114:1248-1259
45. Chen PC, Vargas MR, Pani AK, Smeyne RJ, Johnson DA, Kan YW, Johnson JA: Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte. Proc Natl Acad Sci USA 2009, 106:2933-2938
46. Xue M, Qian Q, Adaikalakoteswari A, Rabbani N, Babaei-Jadidi R, Thornalley PJ: Activation of NF-E2-related factor-2 reverses biochemical dysfunction of endothelial cells induced by hyperglycemia linked to vascular disease. Diabetes 2008, 57:2809-2817
47. Mecocci P, MacGarvey U, Kaufman AE, Koontz D, Shoffner JM, Wallace DC, Beal MF: Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann Neurol 1993, 34:609-616
48. Arnheim N, Cortopassi G: Deleterious mitochondrial DNA mutations accumulate in aging human tissues. Mutat Res 1992, 275:157-167
49. Joyce NC, Harris DL, Zieske JD: Mitotic inhibition of corneal endothelium in neonatal rats. Invest Ophthalmol Vis Sci 1998, 39:2572-2583
50. Shimura-Miura H, Hattori N, Kang D, Miyako K, Nakabeppu Y, Mizuno Y: Increased 8-oxo-dGTPase in the mitochondria of substantia nigral neurons in Parkinson's disease. Ann Neurol 1999, 46:920-924
51. Mecocci P, MacGarvey U, Beal MF: Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 1994, 36:747-751
52. Yakes FM, Van Houten B: Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci USA 1997, 94:514-519
53. Reddy VN, Kasahara E, Hiraoka M, Lin LR, Ho YS: Effects of variation in superoxide dismutases (SOD) on oxidative stress and apoptosis in lens epithelium. Exp Eye Res 2004, 79:859-868
54. Banmeyer I, Marchand C, Clippe A, Knoops B: Human mitochondrial peroxiredoxin 5 protects from mitochondrial DNA damages induced by hydrogen peroxide. FEBS Lett 2005, 579:2327-2333
55. Tuberville AW, Wood TO, McLaughlin BJ: Cytochrome oxidase activity of Fuchs' endothelial dystrophy. Curr Eye Res 1986, 5:939-947